Will These 5 Drug/Biotech Stocks Beat Q1 Earnings Forecast?

The first-quarter 2024 reporting cycle of the Medical sector is currently in full swing. The sector mainly comprises pharma/biotech and medical device companies.With many pharma and biotech bigwigs having already reported results, the earnings picture has been mixed. Although nearly all of these companies have beat bottom-line estimates, some have missed out on the top line. Last week, AbbVie and AstraZeneca reported impressive first-quarter results, with their earnings and sales beating estimates. While As ...